Literature DB >> 32150175

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells.

Suresh Chava1, Suresh Bugide1, Romi Gupta1, Narendra Wajapeyee2.   

Abstract

Natural killer (NK) cells are a subset of the cytotoxic lymphocyte population of the innate immune system and participate as a first line of defense by clearing pathogen-infected, malignant, and stressed cells. The ability of NK cells to eradicate cancer cells makes them an important tool in the fight against cancer. Several new immune-based therapies are under investigation for cancer treatment which rely either on enhancing NK cell activity or increasing the sensitivity of cancer cells to NK cell-mediated eradication. However, to effectively develop these therapeutic approaches, cost-effective in vitro assays to monitor NK cell-mediated cytotoxicity and migration are also needed. Here, we present two in vitro protocols that can reliably and reproducibly monitor the effect of NK-cell cytotoxicity on cancer cells (or other target cells). These protocols are non-radioactivity-based, simple to set up, and can be scaled up for high-throughput screening. We also present a flow cytometry-based protocol to quantitatively monitor NK cell migration, which can also be scaled up for high-throughput screening. Collectively, these three protocols can be used to monitor key aspects of NK cell activity that are necessary for the cells' ability to eradicate dysfunctional target cells.

Entities:  

Mesh:

Year:  2020        PMID: 32150175      PMCID: PMC7213054          DOI: 10.3791/60714

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  30 in total

Review 1.  Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.

Authors:  J A Trapani; J Davis; V R Sutton; M J Smyth
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

Review 2.  The evolution of adaptive immune systems.

Authors:  Max D Cooper; Matthew N Alder
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 3.  The immune system evolved to discriminate infectious nonself from noninfectious self.

Authors:  C A Janeway
Journal:  Immunol Today       Date:  1992-01

Review 4.  Natural innate and adaptive immunity to cancer.

Authors:  Matthew D Vesely; Michael H Kershaw; Robert D Schreiber; Mark J Smyth
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Authors:  Gabriella Pietra; Claudia Manzini; Silvia Rivara; Massimo Vitale; Claudia Cantoni; Andrea Petretto; Mirna Balsamo; Romana Conte; Roberto Benelli; Simona Minghelli; Nicola Solari; Marina Gualco; Paola Queirolo; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Cancer Res       Date:  2012-01-18       Impact factor: 12.701

Review 6.  Immunotherapy of cancer.

Authors:  Hossein Borghaei; Mitchell R Smith; Kerry S Campbell
Journal:  Eur J Pharmacol       Date:  2009-10-20       Impact factor: 4.432

7.  A new immunodeficiency disorder in humans involving NK cells.

Authors:  J C Roder; T Haliotis; M Klein; S Korec; J R Jett; J Ortaldo; R B Heberman; P Katz; A S Fauci
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

Review 8.  Epigenetic regulation of the innate immune response to infection.

Authors:  Qian Zhang; Xuetao Cao
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

9.  A Modified NK Cell Degranulation Assay Applicable for Routine Evaluation of NK Cell Function.

Authors:  Snehal Shabrish; Maya Gupta; Manisha Madkaikar
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

10.  A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry.

Authors:  Srinivas S Somanchi; Kelsey J McCulley; Anitha Somanchi; Leo L Chan; Dean A Lee
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

View more
  2 in total

Review 1.  Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges.

Authors:  Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Mol Ther Oncolytics       Date:  2021-11-29       Impact factor: 7.200

2.  EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.

Authors:  Suresh Bugide; Romi Gupta; Michael R Green; Narendra Wajapeyee
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.